PGY2 Infectious Diseases Pharmacy Resident
The Ohio State University Wexner Medical Center
368 Doan Hall
410 W. 10th Ave
Columbus, OH 43210
614-366-6765
Lindsey.groff@osumc.edu
Professional Interests
I am currently exploring my areas of professional interest through PGY2 residency training. My current practice interests include immunocompromised infectious diseases, mechanisms of resistance, and antimicrobial stewardship with an emphasis on antifungal stewardship.
Education and Training
Residency: Pharmacy (PGY1), The Ohio State University Wexner Medical Center, Columbus, OH
PharmD: The University of Texas at Austin College of Pharmacy, 2019
BS: Health, Texas A&M University College Station, TX, 2014
- Society of Infectious Diseases Pharmacists (SIDP), 2017 – Present
- American College of Clinical Pharmacy (ACCP), 2015 – Present
- American Society of Health-System Pharmacists, 2015 – Present
- Clifton J. Latiolais Message to Garcia Award, 2020
Mostafavifar LG, Groff LT. Leveraging pharmacy residents during COVID-19 pandemic. Am J Health Syst Pharm 2020;77(14):1099-1101.
Evoy KE, Groff L, Hill LG, Godinez W, Gandhi R, Reveles KR. Impact of student pharmacist-led naloxone academic detailing at community pharmacies in Texas. JAPhA 2020;60(1):81-86.
ACCP Clinical Practice Affairs Committee (Hicks JK, Aquilante CL, Dunnenberger HM, Gammal RS, Funk RS, Aitken SL, Bright DR, Coons JC, Dotson KM, Elder CT, Groff LT, Lee JC). ACCP White Paper: Precision pharmacotherapy: integrating pharmacogenomics into clinical practice. J Am Coll Clin Pharm 2019;2:303–313.
Evoy KE, Hill LG, Groff L, Mazin L, Carlson CC, Reveles KR. Naloxone accessibility without a prescriber encounter under standing orders at community pharmacy chains in Texas. JAMA 2018;320:18.